OrthoPediatrics reports preliminary Q4 revenue $31M, consensus $33.8M.

OrthoPediatrics announced preliminary unaudited net revenue for the fourth quarter and full year ended December 31, 2022, and provided 2023 financial guidance. The company said, "Preliminary unaudited fourth quarter 2022 net revenue is expected to be $31.0 million, representing growth of 25% compared to $24.8 million in the fourth quarter of 2021. Preliminary domestic fourth quarter net revenue growth is expected to be 15% compared to the prior year period and international net revenue growth is expected to be 67% compared to the prior year period. Preliminary unaudited full year 2022 net revenue is expected to be $122.3 million, representing growth of 25% compared to $98.0 million in 2021. Preliminary full year domestic net revenue growth is expected to be 19% and international net revenue growth is expected to be 47%."